Lan Yang

1.5k total citations
55 papers, 1.2k citations indexed

About

Lan Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lan Yang has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Lan Yang's work include Ubiquitin and proteasome pathways (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Connexins and lens biology (4 papers). Lan Yang is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Connexins and lens biology (4 papers). Lan Yang collaborates with scholars based in China, United States and Italy. Lan Yang's co-authors include Yanhua Liu, Tong Yang, Yue Sun, Jianzhong Ye, Jianhong Yang, Haitao Li, Chengzhang Wang, Hong Sun, Chengming Zhou and Shijie Wei and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Lan Yang

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Yang China 23 595 216 204 201 182 55 1.2k
Si Chen China 26 952 1.6× 219 1.0× 215 1.1× 128 0.6× 102 0.6× 83 2.0k
Fabrício Figueiró Brazil 26 755 1.3× 250 1.2× 202 1.0× 213 1.1× 245 1.3× 81 1.9k
Amir R. Afshari Iran 25 753 1.3× 219 1.0× 249 1.2× 158 0.8× 166 0.9× 76 1.7k
Donghui Zheng China 24 667 1.1× 131 0.6× 332 1.6× 325 1.6× 169 0.9× 62 1.5k
Xiaojun Tao China 23 588 1.0× 128 0.6× 153 0.8× 214 1.1× 315 1.7× 58 1.3k
Mysore S. Veena United States 19 944 1.6× 308 1.4× 327 1.6× 88 0.4× 168 0.9× 28 1.9k
Frederick Luk Australia 15 897 1.5× 371 1.7× 402 2.0× 130 0.6× 177 1.0× 16 1.5k
Ying Cheng China 19 514 0.9× 139 0.6× 153 0.8× 184 0.9× 153 0.8× 50 1.1k
Amit Singh Yadav India 18 528 0.9× 216 1.0× 194 1.0× 275 1.4× 225 1.2× 40 1.3k

Countries citing papers authored by Lan Yang

Since Specialization
Citations

This map shows the geographic impact of Lan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Yang more than expected).

Fields of papers citing papers by Lan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Yang. The network helps show where Lan Yang may publish in the future.

Co-authorship network of co-authors of Lan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Yang. A scholar is included among the top collaborators of Lan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Yang. Lan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yang, Zheng Wang, Zhong Jin, et al.. (2023). Paeonol Promotes Reendothelialization After Vascular Injury Through Activation of c-Myc/VEGFR2 Signaling Pathway. Drug Design Development and Therapy. Volume 17. 1567–1582. 5 indexed citations
3.
Liang, Qiangwei, et al.. (2022). Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy. European Journal of Pharmaceutics and Biopharmaceutics. 177. 260–272. 21 indexed citations
4.
Yang, Lan, Jiayu Yang, Yue Sun, et al.. (2021). Simultaneous Determination of 1-Methyltryptophan and Indoleamine 2,3-Dioxygenase Biomakers of Tryptophan and Kynurenine in Mice Tumors by HPLC–MS/MS. Chromatographia. 84(7). 623–634. 1 indexed citations
5.
Ma, Yiming, Xinhua Zhao, Weiwei Li, et al.. (2021). Protease activated receptor 2 signaling promotes self-renewal and metastasis in colorectal cancer through β-catenin and periostin. Cancer Letters. 521. 130–141. 16 indexed citations
6.
Yang, Lan, Qiangwei Liang, Yue Sun, et al.. (2020). Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy. ACS Applied Materials & Interfaces. 12(28). 31904–31921. 42 indexed citations
7.
Wang, Lihong, Jia Ge, Lan Yang, et al.. (2020). Tumor mutational burden is associated with poor outcomes in diffuse glioma. BMC Cancer. 20(1). 213–213. 56 indexed citations
8.
Liu, Huijuan, Yuan Qin, Qiang Zhang, et al.. (2019). Antimalarial Drug Pyrimethamine Plays a Dual Role in Antitumor Proliferation and Metastasis through Targeting DHFR and TP. Molecular Cancer Therapeutics. 18(3). 541–555. 35 indexed citations
9.
Yang, Tong, et al.. (2019). Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer. Molecular Pharmaceutics. 16(6). 2502–2510. 26 indexed citations
10.
Yang, Lan, Yue Sun, Tong Yang, et al.. (2019). Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Molecular Pharmaceutics. 16(8). 3430–3440. 43 indexed citations
11.
Liu, Fangyuan, Ling Wang, Jialing Fu, et al.. (2019). Analysis of Non-Sumoylated and Sumoylated Isoforms of Pax-6, the Master Regulator for Eye and Brain Development in Ocular Cell Lines. Current Molecular Medicine. 18(8). 566–573. 2 indexed citations
12.
Yang, Tong, Lan Yang, Mei Cao, et al.. (2018). Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer. Colloids and Surfaces B Biointerfaces. 175. 106–115. 60 indexed citations
13.
Yang, Lan, Yiming Ma, Weiwei Li, et al.. (2015). Proteinase-activated Receptor 2 Promotes Cancer Cell Migration through RNA Methylation-mediated Repression of miR-125b. Journal of Biological Chemistry. 290(44). 26627–26637. 60 indexed citations
15.
He, Fan, Qiong Wang, Xuelian Zheng, et al.. (2012). Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species. Oncology Reports. 28(2). 601–605. 47 indexed citations
16.
Yang, Lan. (2011). Effects of SCF on the expressions of c-kit mRNA and protein of interstitial cells of Cajal-like cells in the bladder of guinea pig in the high glucose environment. Experimental Pathology.
18.
Shi, Fang, Xuelian Zheng, Qiong Wang, et al.. (2011). Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms. Acta Pharmacologica Sinica. 32(12). 1529–1536. 36 indexed citations
19.
Yang, Lan, Chengzhang Wang, Jianzhong Ye, & Haitao Li. (2011). Hepatoprotective effects of polyprenols from Ginkgo biloba L. leaves on CCl4-induced hepatotoxicity in rats. Fitoterapia. 82(6). 834–840. 77 indexed citations
20.
Wang, Yuancheng, et al.. (2003). Oxidized LDL induces transcription factor activator protein‐1 in rat mesangial cells. Cell Biochemistry and Function. 21(3). 249–256. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026